RS Research is a pharmaceutical company developing next generation of nano-medicines
based on innovative drug delivery platforms.
RS Research has been founded in 2015 as an academic spin-off by Rana Sanyal and Sena Nomak.
Technology focused venture capital fund ACT Venture Partners, has invested 1.1 million Euros in RS Research.
As a result of promising results from pre-clinical studies, RS Research started preparations for phase-1 clinical trials.